A PHASE III, RANDOMIZED, DOUBLE BLIND, CONTROLLED WITH PLACEBO TRIAL OF ORAL SUBEROILANILIDE HYDROXAMIC ACID (VORINOSTAT, MK 0683), IN PATIENTS WITH ADVANCED MALIGNO PLEURAL MESOTELIOMA, PRE-THERMOTALLY TREATED.

Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2009
This article has no abstract
Epistemonikos ID: 996329439cd58007792d4b88eb687126ab50f515
First added on: Apr 16, 2025